Pure Global Cannabis Inc. (TSXV:PURE) distinguishes itself by leveraging innovative cultivation techniques to deliver industry-leading production yields
SmallCapPower | November 14, 2018: Pure Global Cannabis Inc. (TSXV:PURE) is focused on cultivating and refining cannabis products for sale in the medicinal and recreational markets. Located in Brampton Ontario, the Company utilizes hydroponic cultivation to generate industry-high yields. Pure Global Cannabis is one of the many exciting cannabis companies presenting at the New Green Frontier Cannabis Conference on November 19, 2018. Investors can sign up for the free webcast or register to attend in person here.
For Our Complete Coverage Of Canadian Marijuana Stocks Click Here
Here’s the three most compelling investment highlights for Pure Global Cannabis:
- Multiponic cultivation techniques give industry-leading production yields
- Appletree Medical Group partnership places strategic foothold in health and wellness industry
- Facility expansion on target for completion in Q1/2019
Pure Global Cannabis is an industry leader in cannabis production. Combining the best practices of hydroponics (growing cannabis without soil using nutrient-rich water) and aeroponics (cultivation in a mist environment), Pure Global Cannabis has developed a vertically-integrated, patent-pending, cultivation technique known as ‘multiponics’. Multiponic cultivation allows for between 2-3 stacked canopy tiers, allowing for more efficient utilization of space during production. Pure Global Cannabis has industry-leading cultivation yields of 300 grams per square foot compared to industry peer yields of ~90 grams/sq. ft. (Forbes).
Strategic partnership provides foothold in health & wellness market. In September 2018, Pure Global Cannabis announced a partnership with Appletree Medical Group to launch an occupational study on the efficacy of different cannabis strains in the treatment of medical conditions. Findings will be leveraged by Pure Global Cannabis to develop pharmaceutical-grade cannabis products for the health and wellness industry, a market estimated at over a trillion dollars worldwide.
Facility expansion on track for 2019, set to drastically increase Pure’s production. Pure Global Cannabis’ Phase 2 & 3 facility expansion is expected to be completed in Q1/2019. Phase 2 will increase the facility to 18,000 sq. ft., with an estimated production of 4,000 kg/year through vertically-integrated cultivation. Phase 3 will complete the Company’s research and development laboratory and expand the facility size to 41,000 sq. ft., increasing production to a cumulative ~8,000 kg/year.
Disclosure: Neither the author nor his family own shares in the company mentioned above.
To read our full disclosure, please click on the button below:
